A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease.
Study Goal
The researchers aimed to evaluate the feasibility, acceptability, and effectiveness of a mindfulness-based intervention for patients with inflammatory bowel disease (IBD).
Results Summary
The mindfulness intervention group showed significant improvements in anxiety, quality of life, and mindfulness post-intervention, with sustained reductions in depression and improvements in quality of life and mindfulness at 6 months. The study concluded that the intervention was feasible, acceptable, and effective for IBD patients.
Population
Patients with inflammatory bowel disease (IBD).
Effective Dosage
8-week mindfulness-based stress reduction training group (specific daily minutes meditated not quantified in abstract).
Duration
8 weeks, with follow-up at 6 months post-intervention.
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
mindfulness-based stress reduction intervention | decrease | anxiety | patients with inflammatory bowel disease | - | significantly greater improvements | #1 |
mindfulness-based stress reduction intervention | increase | quality of life | patients with inflammatory bowel disease | - | significantly greater improvements | #2 |
mindfulness-based stress reduction intervention | increase | mindfulness | patients with inflammatory bowel disease | - | significantly greater improvements | #3 |
mindfulness-based stress reduction intervention | decrease | depression | patients with inflammatory bowel disease | - | reduction | #4 |
mindfulness-based stress reduction intervention | increase | quality of life | patients with inflammatory bowel disease | - | improvements | #5 |
mindfulness-based stress reduction intervention | increase | mindfulness | patients with inflammatory bowel disease | - | improvements | #6 |
BACKGROUND: This study aimed to evaluate the feasibility, acceptability, and effectiveness of a mindfulness-based intervention for patients with inflammatory bowel disease (MI-IBD). DESIGN: Treatment-as-usual control versus mindfulness-based stress reduction intervention. METHODS: Sixty patients participated in either the MI-IBD (n = 33) or treatment-as-usual group (n = 27) conditions. The MI-IBD consisted of an 8-week mindfulness-based stress reduction training group. Outcome measures were administered at baseline (before intervention), immediately after intervention, and 6 months after intervention. Primary outcomes included measures of quality of life, psychological distress (depression and anxiety), and mindfulness. Data for MI-IBD group participants also included weekly attendance, daily minutes meditated, and satisfaction with the program. RESULTS: There were no baseline differences between intervention and control groups on demographic variables or inflammatory bowel disease severity. Compared with the control group, the MI-IBD group reported significantly greater improvements in anxiety, quality of life, and mindfulness at after intervention, with reduction in depression and improvements in quality of life and mindfulness maintained at 6 months after intervention. CONCLUSIONS: Results demonstrate the feasibility, acceptability, and efficacy of a mindfulness intervention for patients with inflammatory bowel disease, with medium-to-large effects on psychological distress, quality of life, and mindfulness.